Literature DB >> 32551551

Cell Surface Remodeling of Mycobacterium abscessus under Cystic Fibrosis Airway Growth Conditions.

Crystal J Wiersma1, Juan Manuel Belardinelli1, Charlotte Avanzi1, Shiva Kumar Angala1, Isobel Everall2,3, Bhanupriya Angala1, Edward Kendall1, Vinicius Calado Nogueira de Moura1, Deepshikha Verma1, Jeanne Benoit4, Karen P Brown2,5, Victoria Jones1, Kenneth C Malcolm6,7, Michael Strong4,7, Jerry A Nick6,7, R Andres Floto2,5, Julian Parkhill3,8, Diane J Ordway1, Rebecca M Davidson4, Michael R McNeil1, Mary Jackson1.   

Abstract

Understanding the physiological processes underlying the ability of Mycobacterium abscessus to become a chronic pathogen of the cystic fibrosis (CF) lung is important to the development of prophylactic and therapeutic strategies to better control and treat pulmonary infections caused by these bacteria. Gene expression profiling of a diversity of M. abscessus complex isolates points to amino acids being significant sources of carbon and energy for M. abscessus in both CF sputum and synthetic CF medium and to the bacterium undergoing an important metabolic reprogramming in order to adapt to this particular nutritional environment. Cell envelope analyses conducted on the same representative isolates further revealed unexpected structural alterations in major cell surface glycolipids known as the glycopeptidolipids (GPLs). Besides showing an increase in triglycosylated forms of these lipids, CF sputum- and synthetic CF medium-grown isolates presented as yet unknown forms of GPLs representing as much as 10% to 20% of the total GPL content of the cells, in which the classical amino alcohol located at the carboxy terminal of the peptide, alaninol, is replaced with the branched-chain amino alcohol leucinol. Importantly, both these lipid changes were exacerbated by the presence of mucin in the culture medium. Collectively, our results reveal potential new drug targets against M. abscessus in the CF airway and point to mucin as an important host signal modulating the cell surface composition of this pathogen.

Entities:  

Keywords:  Mycobacterium abscessus; branched-chain amino acids; cystic fibrosis; glycopeptidolipids; mucin; synthetic cystic fibrosis medium

Mesh:

Substances:

Year:  2020        PMID: 32551551     DOI: 10.1021/acsinfecdis.0c00214

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  4 in total

1.  Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus.

Authors:  Juan Manuel Belardinelli; Deepshikha Verma; Wei Li; Charlotte Avanzi; Crystal J Wiersma; John T Williams; Benjamin K Johnson; Matthew Zimmerman; Nicholas Whittel; Bhanupriya Angala; Han Wang; Victoria Jones; Véronique Dartois; Vinicius C N de Moura; Mercedes Gonzalez-Juarrero; Camron Pearce; Alan R Schenkel; Kenneth C Malcolm; Jerry A Nick; Susan A Charman; Timothy N C Wells; Brendan K Podell; Jonathan L Vennerstrom; Diane J Ordway; Robert B Abramovitch; Mary Jackson
Journal:  Sci Transl Med       Date:  2022-02-23       Impact factor: 19.319

Review 2.  Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design.

Authors:  Kia C Ferrell; Matt D Johansen; James A Triccas; Claudio Counoupas
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

Review 3.  Synthesis and recycling of the mycobacterial cell envelope.

Authors:  Katherine A Abrahams; Gurdyal S Besra
Journal:  Curr Opin Microbiol       Date:  2021-02-18       Impact factor: 7.934

4.  2-Aminoimidazoles Inhibit Mycobacterium abscessus Biofilms in a Zinc-Dependent Manner.

Authors:  Juan M Belardinelli; Wei Li; Kevin H Martin; Michael J Zeiler; Elena Lian; Charlotte Avanzi; Crystal J Wiersma; Tuan Vu Nguyen; Bhanupriya Angala; Vinicius C N de Moura; Victoria Jones; Bradley R Borlee; Christian Melander; Mary Jackson
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.